Tuesday December 12, 2017 02:11

Heathcare Press Release : 06 Dec 2017

JOHNSON JOHNSON THAILAND PROVIDES HOLISTIC DIABETES CARE SOLUTIONS WITH NEW IN-STORE PROGRAM AT FASCINO TO MARK WORLD DIABETES DAY Heathcare—06 Dec 17

Johnson & Johnson (Thailand) Limited marked World Diabetes Day this month by launching a new in-store holistic diabetes care program at FASCINO, one of the leading pharmacy chains operating in Thailand. The program aims to provide access to diabetes

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Cardiovascular Risk Heathcare—06 Dec 17

ABU DHABI, UAE--6 Dec--PRNewswire/InfoQuest

Today the International Diabetes Federation (IDF) presented the interim results of the first ever multi-country online survey on CVD risk awareness and knowledge among people living with type 2 diabetes, indicating low levels of awareness and limited dialogue between patients and healthcare professionals. The global survey - Taking Diabetes to Heart - developed in partnership with Novo Nordisk, runs until March 2018 and is open to all people with type 2 diabetes.

Diabetes currently affects 425 million adults worldwide[1], with most cases being type 2 diabetes. Cardiovascular disease, which includes stroke, coronary heart disease and peripheral artery disease[3], is the leading cause of disability and death in people with type 2 diabetes[1],[4].

To date, 943 responses to the survey have been received from 32 countries a

Switching to Tresiba(R) Benefits People with Diabetes Irrespective of Blood Sugar Levels in a Heathcare—06 Dec 17

- Switching to Tresiba(R) reduced the rate of hypoglycaemia by 67% in people with controlled blood sugar levels - In people with diabetes whose blood sugar was too high, switching to Tresiba(R) significantly improved blood sugar levels Switching to

Merck Announces FDA 510(k) Clearance of Partner Genea Biomedx#s Fertility Benchtop Incubator Heathcare—06 Dec 17

- Expanded Fertility Technology portfolio highlights Merck's commitment to improve fertility treatment outcomes for patients - U.S. commercial availability expected in first half of 2018 Merck, a leading science and technology company, today announced

Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Heathcare—06 Dec 17

Medical Microinstruments S.r.l. (MMI), a developer of novel robotic solutions for unmet medical needs, today reveals its robotic platform specifically designed for open microsurgery. The platform allows the surgeon to control two tiny articulated

Xultophy(R) Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Heathcare—06 Dec 17

Once-daily Xultophy(R) (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on